Board MeetingOutcome of Board Meeting
AstraZeneca Pharma India Board met, approved Q1 results: Revenue soared 30% to ₹682.8 Cr, profit hit ₹50.7 Cr.
AstraZeneca Pharma India LimitedASTRAZEN · Filed with the exchange
Arun Krishna joined as Addl.
Director; Bhavana Agrawal's role changed.
Company also secured key drug approvals and launched strategic initiatives.
No comments yet. Be the first.